Azevedo, J., DiRaimo, J., Neunert, C., Cooper, N., & Grace, R. F. (2025). Treatment Landscape in Pediatric Immune Thrombocytopenia: Addressing Unmet Needs. Pediatric Blood & Cancer, 72(7). Portico. https://doi.org/10.1002/pbc.31758

Kim, T. O., Geris, J. M., Flanagan, J. M., Grace, R. F., Lambert, M. P., O’Farrell, C., Rose, M. J., Shimano, K. A., Niss, O., Neunert, C., Nakano, T. A., MacMath, D., Dinu, B., Kirk, S. E., Neufeld, E. J., Despotovic, J. M., Scheurer, M. E., & Grimes, A. B. (2024). Genetic variants in canonical Wnt signaling pathway associated with pediatric immune thrombocytopenia. Blood Advances, 8(21), 5529–5538. https://doi.org/10.1182/bloodadvances.2024012776

Neunert, C. E., Arnold, D. M., Grace, R. F., Kuhne, T., McCrae, K. R., & Terrell, D. R. (2024). The 2022 review of the 2019 American Society of Hematology guidelines on immune thrombocytopenia. Blood Advances, 8(13), 3578–3582. https://doi.org/10.1182/bloodadvances.2023012541

Neunert, C., Heitink‐Polle, K. M. J., & Lambert, M. P. (2023). A proposal for new definition (s) and management approach to paediatric refractory ITP: Reflections from the Intercontinental ITP Study Group. British Journal of Haematology, 203(1), 17–22. Portico. https://doi.org/10.1111/bjh.19072

Hillier, K., Rothman, J. A., Klaassen, R. J., Neunert, C., Rose, M. J., Grace, R. F., & Lambert, M. P. (2022). SARS‐CoV‐2 vaccination in pediatric patients with immune thrombocytopenia. Pediatric Blood & Cancer, 69(7). Portico. https://doi.org/10.1002/pbc.29760

Shimano, K. A., Grace, R. F., Despotovic, J. M., Neufeld, E. J., Klaassen, R. J., Bennett, C. M., Ma, C., London, W. B., & Neunert, C. (2021). Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol. BMJ Open, 11(8), e044885. https://doi.org/10.1136/bmjopen-2020-044885